quinacrine has been researched along with Eye Manifestations in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Eye Manifestations: Ocular disorders attendant upon non-ocular disease or injury.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
TUFFANELLI, D | 1 |
ABRAHAM, RK | 1 |
DUBOIS, EI | 1 |
Voog, R | 1 |
Chouteau, J | 1 |
Marchal, A | 1 |
Cabanel, G | 1 |
2 other studies available for quinacrine and Eye Manifestations
Article | Year |
---|---|
PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS.
Topics: Antimalarials; Arthritis; Arthritis, Rheumatoid; Chloroquine; Cornea; Eye; Eye Manifestations; Histo | 1963 |
[Asthma therapy with a combination of synthetic antimalarials (83 cases)].
Topics: Adolescent; Adult; Aged; Asthma; Chloroquine; Drug Synergism; Electrocardiography; Eosinophilia; Eye | 1969 |